Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
A common denominator among the multiple damage-inducing agents that ultimately lead to activation of NLRP3 has not yet been identified. Recently, production of reactive oxygen species (ROS) has been suggested to act as a common event upstream of the NLRP3 inflammasome machinery. Because de novo translation of NLRP3 is an essential step in the activation of NLRP3, we investigated the role of substances that inhibit either ROS production or its oxidative activity. Although we observe that NLRP3 inflammasome activation is unique among other known inflammasomes in its sensitivity to ROS inhibition, we have found that this phenomenon is attributable to the fact that NLRP3 strictly requires priming by a proinflammatory signal, a step that is blocked by ROS inhibitors. Although these data do not exclude a general role for ROS production in the process of NLRP3-triggered inflammation, they would put ROS upstream of NLRP3 induction, but not activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, these toxins mediate increased ROS production, which activates intrinsic apoptotic pathways and the NLRP3 inflammasome, thereby inflicting cytotoxicity in keratinocytes, neutrophils, and other tissue cells [14].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 1×
“Owing to the highly proinflammatory potential of bioactive IL-1b, its release is a tightly controlled process, in which caspase-1–mediated cleavage of pro–IL-1b is a rate-limiting step (1).”
BackgroundCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · cited 1×
“To this effect, it has also been demonstrated that inhibitors of mitochondrial ROS production (17) and the knocking down of mitochondrial respiration by targeting the expression of voltage-dependent anion channels (18) downmodulate NLRP3-mediated inflammasome activation.”
BackgroundBauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959 · cited 4×
“Macrophages stably overexpressing NLRP3 were obtained through lentiviral transduction, as explained earlier (10).”
BackgroundMethodSelf-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
Self-citationAIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., & Alnemri, E. S. (2009) · Nature · doi:10.1038/nature07710 · Cited by 1,831
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Cited by
Items 201–300 of 676
Pathogenic Fungus Microsporum canis Activates the NLRP3 Inflammasome
Mao, L., Zhang, L., Li, H., Chen, W., Wang, H., Wu, S., Guo, C., Lu, A., Yang, G., An, L., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01097-13 · Cited by 91
“A recent report showed that in mouse macrophages, ROS inhibitors such as DPI and NAC abolished IL-1 release through inhibition of the expression of NLRP3 and pro-IL-1 (57).”
BackgroundPyroptosis in diabetic nephropathy
Mamun, A. A., Mimi, A. A., Wu, Y., Zaeem, M., Aziz, M. A., Suchi, S. A., Alyafeai, E., Munir, F., & Xiao, J. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.09.003 · Cited by 90
Org, E., Mehrabian, M., & Lusis, A. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.035 · Cited by 85
Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway
Yu, Q., Zhang, M., Qian, L., Wen, D., & Wu, G. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.073 · Cited by 89
Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
Feng, Y.-S., Tan, Z., Wang, M., Xing, Y., Dong, F., & Zhang, F. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00155 · Cited by 89
The NLRP3 Inflammasome: Role and Therapeutic Potential in Pain Treatment
Starobova, H., Nadar, E. I., & Vetter, I. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01016 · Cited by 89
“…events such as potassium ion efflux, changes in calcium signaling, increase in production of reactive oxygen species by mitochondria or lysosomal leakage and release of cathepsin-B (Figure 1A; Brough et al., 2003; Bauernfeind et al., 2011; MunozPlanillo et al., 2013; Orlowski et al., 2015).”
BackgroundNegative regulation of NLRP3 inflammasome signaling
Chen, S., & Sun, B. (2013) · Protein & Cell · doi:10.1007/s13238-013-2128-8 · Cited by 83
Inflammasome and cytokine blocking strategies in autoinflammatory disorders
Moll, M., & Kuemmerle-Deschner, J. B. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.04.008 · Cited by 90
The NLRP 3 inflammasome: role in airway inflammation
Im, H., & Ammit, A. J. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12206 · Cited by 79
Hua, K., Yang, S., Kao, T.-Y., Chang, J., Chen, H., Tsai, Y.-J., Chen, A., Yang, S., Chao, L. K., & Ka, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077794 · Cited by 87
“We [48] and others [49,50] have shown that NFkB induces NLRP3 expression and NLRP3 inflammasome activity.”
BackgroundKim, T.-H., Kang, M. S., Mandakhbayar, N., El‐Fiqi, A., & Kim, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.03.034 · Cited by 87
Pirzada, R. H., Javaid, N., & Choi, S. (2020) · Genes · doi:10.3390/genes11020131 · Cited by 87
“On the other hand, opposing evidence highlights the controversial role of mitochondrial ROS in the inhibition of NLRP3 activation [41].”
BackgroundInflammasome inhibitors: promising therapeutic approaches against cancer
Xu, S., Li, X., Liu, Y., Xia, Y., Chang, R., & Zhang, C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0755-0 · Cited by 86
“Notably, the involvement of mitochondrial reactive oxygen species (mtROS) continues to be debated [25].”
BackgroundComplement C5a potentiates uric acid crystal‐induced IL‐1β production
An, L., Mehta, P., Xu, L., Turman, S., Reimer, T., Naiman, B., Connor, J., Sanjuan, M., Kolbeck, R., & Fung, M. (2014) · European Journal of Immunology · doi:10.1002/eji.201444560 · Cited by 70
Isorhamnetin and hyperoside derived from water dropwort inhibits inflammasome activation
Ahn, H., & Lee, G. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.11.019 · Cited by 85
“Regulaion of the priming step, when pro-IL-1 β and NLRP3 genes are upegulated by NF- κB signaling and/or reactive oxygen species (ROS) roduction, is another gatekeeper for NLRP3 inflammasome activaion ( Bauernfeind et al., 2011; Bauernfeind et al., 2009 ).”
BackgroundThe machinery of Nod‐like receptors: refining the paths to immunity and cell death
Saleh, M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01045.x · Cited by 71
“More recently, the effects of ROS production in the process of NLRP3-triggered inflammation were mapped to upstream of NLRP3 transcriptional induction and not to direct activation of NLRP3 inflammasome complex formation, as previously speculated (35).”
BackgroundNLRP3 inflammasome as a sensor of micro- and nanoplastics immunotoxicity
Alijagić, A., Hedbrant, A., Persson, A., Larsson, M., Engwall, M., & Särndahl, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1178434 · Cited by 85
NLRP3 Inflammasome Activation by Paracoccidioides brasiliensis
Tavares, A. H., Magalhães, K. G., Almeida, R. D. N., Corrêa, R., Bürgel, P. H., & Bocca, A. L. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002595 · Cited by 83
“dant or free radical scavenger NAC, a concomitant reduction in both IL-1b and TNF-a secretion was observed, which is in line with the finding that NAC, unlike APDC, inhibit NF-kB activation [21,36].”
BackgroundResultFrom Mitochondria to Atherosclerosis: The Inflammation Path
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., & Sánchez-Alcázar, J. A. (2021) · Biomedicines · doi:10.3390/biomedicines9030258 · Cited by 81
“Despite the fact that ROS scavengers such as N-acetyl-lysine (NAC) reduce the transcription of NLRP3 and pro-IL-1β, they have no apparent effect on mitochondrial ROS [135].”
BackgroundHanley, P. J., Kronlage, M., Kirschning, C., del Rey, A., Di Virgilio, F., Leipziger, J., Chessell, I. P., Sargin, S., Filippov, M. A., Lindemann, O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.332676 · Cited by 70
Role of Inflammasomes in Intestinal Inflammation and Crohnʼs Disease
Opipari, A. W., & Franchi, L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000230 · Cited by 81
“Exposure to microbial products or any of a number of proinflammatory cytokines increases expression of both pro-IL-1b and NLRP3 allowing subsequent activation.(42,43) The cognate stimuli to activate preformed NLRP3 include”
BackgroundSelf-citationYang, S.-M., Ka, S., Hua, K., Wu, T., Chuang, Y.-P., Lin, Y., Yang, F.-L., Wu, S., Yang, S.-S., Lin, S., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.024 · Cited by 81
Current status of inflammasome blockers as anti-inflammatory drugs
López-Castejón, G., & Pelegrín, P. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.690032 · Cited by 75
“In particular, ROS inhibitors prevent pro-IL-1b synthesis and NLRP3 expression [64].”
BackgroundEffects of hydrogen-rich water on depressive-like behavior in mice
Zhang, Y., Su, W.-J., Chen, Y., Wu, T.-Y., Gong, H., Shen, X.-L., Wang, Y.-X., Sun, X.-J., & Jiang, C.-L. (2016) · Scientific Reports · doi:10.1038/srep23742 · Cited by 79
Copper Regulates the Canonical NLRP3 Inflammasome
Deigendesch, N., Zychlinsky, A., & Meissner, F. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700712 · Cited by 79
“As previously shown (14), treatment with diphenyliodonium, a commonly used inhibitor of NOX-dependent ROS production (51), blocked LPS priming efficiently; in contrast, diphenyliodonium treatment after LPS priming had no effect on inflammasome activation and did not affect TTM activity (Supplemental Fig.”
MethodPiippo, N., Korhonen, E., Hytti, M., Kinnunen, K., Kaarniranta, K., & Kauppinen, A. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492886 · Cited by 79
Involvement of Inflammasome Components in Kidney Disease
Aranda‐Rivera, A. K., Srivastava, A., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., Mulay, S. R., & Scholze, A. (2022) · Antioxidants · doi:10.3390/antiox11020246 · Cited by 79
“The latter has been demonstrated by ROS inhibitors that blocked the priming steps of inflammasome [83,84].”
BackgroundLi, L., & Tian, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114504 · Cited by 79
Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
Pagliaro, P., & Penna, C. R. R. (2023) · Antioxidants · doi:10.3390/antiox12071396 · Cited by 79
“, LPS/ATP, LPS/nigericin, or LPS/silica) [52].”
iGLuc: a luciferase-based inflammasome and protease activity reporter
Bartok, E., Bauernfeind, F. G., Khaminets, M. G., Jakobs, C., Monks, B. G., Fitzgerald, K. A., Latz, E., & Hornung, V. (2013) · Nature Methods · doi:10.1038/nmeth.2327 · Cited by 79
Self-citationGong, H., Gao, X., Feng, S., Siddiqui, M. R., Garcia, A. N., Bonini, M. G., Komarova, Y. A., Vogel, S. M., Mehta, D., & Malik, A. B. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131190 · Cited by 79
“That the global ROS scavenger NAC (Shimizu et al., 2004; Bauernfeind et al., 2011) and Nox inhibitor DPI (Wind et al., 2010; Bauernfeind et al., 2011) prevented the binding of G13 with VE-cadherin supported our contention that AJ disassembly and permeability responses were initiated by ROS production induced by the in…”
BackgroundInfluentialNLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders?
Zhou, F., Li, C., & Zhang, S. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001214 · Cited by 79
“A significantly increased expression of the endometrial NLRP3 inflammasome, and of caspase-1-dependent secretion of IL-1b and IL-18 were demonstrated in endometrial tissues obtained from women with RSA compared with a control group (fertile women).([39,40]) Thus, the NLRP3 inflammasome might represent a novel family o…”
BackgroundHu, Z., Wang, B., Zhou, X., Liang, H., Liang, B., Lu, H.-W., Ge, Y., Chen, Q., Tian, Q., Xue, F., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c05005 · Cited by 78
The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation
Xia, J., Jiang, S., Dong, S., Liao, Y., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076126 · Cited by 77
Interplay between redox status and inflammasome activation
Rubartelli, A., Gattorno, M., Netea, M. G., & Dinarello, C. A. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.08.005 · Cited by 77
Interplay between Inflammation and Cellular Stress Triggered by Flaviviridae Viruses
Valadão, A. L. C., Aguiar, R. S., & de Arruda, L. B. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01233 · Cited by 77
“Several NLRP3 activators are associated with ROS production, which, in turn may be either important for NLRP3 activation or expression (Bauernfeind et al., 2011; Rahman and McFadden, 2011; Zhou et al., 2011).”
BackgroundLiang, X., Zhang, D., Liu, W., Yan, Y., Zhou, F., Wu, W., & Yan, Z. (2017) · Toxicology and Industrial Health · doi:10.1177/0748233717712409 · Cited by 67
“The ROS inhibitors including diphenyliodonium (DPI) had been reported to potently inhibit NLRP3 activation (Cassel et al., 2008) and DPI potently inhibited caspase-1 activation in response to various NLRP3 stimuli (LPS/nigericin or LPS/silica) (Bauernfeind et al., 2011).”
BackgroundMetaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Mastrocola, R., Aragno, M., Alloatti, G., Collino, M., Penna, C., & Pagliaro, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170407123522 · Cited by 76
“A recent study has proposed that ROS are necessary for priming the NLRP3 inflammasome, but not for its activation [38].”
BackgroundInflammasome activation via intracellular NLRs triggered by bacterial infection
Koizumi, Y., Toma, C., Higa, N., Nohara, T., Nakasone, N., & Suzuki, T. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01707.x · Cited by 75
“A recent study has shown that ROS production is required to prime NLRP3, but not for the activation of the inflammasome itself (Bauernfeind et al., 2011).”
BackgroundLavieri, R., Piccioli, P., Carta, S., Delfino, L., Castellani, P., & Rubartelli, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303480 · Cited by 75
“Production of reactive oxygen species (ROS) and the consequent redox signaling are required for IL-1b induction (16, 17) and inflammasome-mediated IL-1b secretion (18).”
BackgroundKapétanovic, R., Bokil, N. J., & Sweet, M. J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.02.005 · Cited by 75
mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus
Li, X., Zhang, B., Pan, Y., Shi, G., Ren, J., Fan, H., Dou, H., & Hou, Y. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy088 · Cited by 75
Chiu, H., Li, L.-H., Hsieh, C., Rao, Y. K., Chen, F.-H., Chen, A., Ka, S., & Hua, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42130-z · Cited by 75
The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
Jiang, H., Gong, T., & Zhou, R. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.003 · Cited by 74
Inflammasome biology in fibrogenesis
Ouyang, X., Ghani, A., & Mehal, W. Z. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.020 · Cited by 74
Orlowski, G. M., Sharma, S., Colbert, J. D., Bogyo, M., Robertson, S. A., Kataoka, H., Chan, F. K., & Rock, K. L. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0316-152r · Cited by 65
“The first signal (“priming”) can be initiated through a receptor (eg, TLR4), which leads to the activation of the transcription factor NF-kB, which then drives the transcription of pro–IL-1b and NLRP3 [19, 20].”
BackgroundLawana, V., Singh, N., Sarkar, S., Charli, A., Jin, H., Anantharam, V., Kanthasamy, A. G., & Kanthasamy, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9746-5 · Cited by 73
“Studies have implicated ROS-derived from dysfunctional mitochondria may be linked to sustained NLRP3 inflammasome activation and IL-1β secretion (Tschopp and Schroder 2010; Bauernfeind et al. 2011; Zhou et al. 2011; Kauppinen et al. 2012; Chen et al. 2015; Jang et al. 2015).”
BackgroundNew tricks from an old dog: Mitochondrial redox signaling in cellular inflammation
Pelletier, M., Lepow, T. S., Billingham, L. K., Murphy, M. P., & Siegel, R. M. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2013.01.002 · Cited by 64
Wong, W.-T., Li, L., Rao, Y. K., Yang, S., Cheng, S., Lin, W., Cheng, C., Chen, A., & Hua, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01920 · Cited by 72
“Intracellular ROS production was measured by staining the cells with 2′,7′- dichlorofluorescein diacetate (2µM) (Molecular Probes, Eugene, OR) as described previously (18).”
BackgroundInfluentialInflammasome activation: from molecular mechanisms to autoinflammation
Reyna, S. J. L., Caseley, E. A., Topping, J., Rodrigues, F., Jimenez-Macias, J. L., Lawler, S. E., & McDermott, M. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1404 · Cited by 73
Maier, N. K., Crown, D., Liu, J., Leppla, S. H., & Moayeri, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301434 · Cited by 71
“Paradoxically, some investigators have found that ROS production can be an activation signal for the NLRP3 inflammasome (37) and that ROS causes the induction of NLRP3 expression (38).”
BackgroundThe NLRP3 inflammasome: role in the pathobiology of chronic pain
Chen, C., & Smith, M. T. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01235-8 · Cited by 71
Rada, B., Park, J. J., Sil, P., Geiszt, M., & Leto, T. L. (2014) · Inflammation Research · doi:10.1007/s00011-014-0756-y · Cited by 58
“Another study suggests that ROS are only required for inflammasome priming but not for activation [48].”
Loria, J. R. D., Rohmann, K., Droemann, D., Kujath, P., Rupp, J., Goldmann, T., & Dalhoff, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066818 · Cited by 70
“ROS inhibition was only successful when performed before NTHi stimulation (data not shown), suggesting a predominant effect of ROS inhibition on priming by proinflammatory signals [12].”
BackgroundBolívar, B. E., Vogel, T. P., & Bouchier‐Hayes, L. (2019) · FEBS Journal · doi:10.1111/febs.14926 · Cited by 70
Savic, S., Dickie, L. J., Wittmann, M., & McDermott, M. (2012) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2012.07.009 · Cited by 70
Methylene blue inhibits NLRP3, NLRC4, AIM2, and non-canonical inflammasome activation
Ahn, H., Kang, S. G., Yoon, S., Ko, H., Kim, P.-H., Hong, E., An, B., Lee, E., & Lee, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-12635-6 · Cited by 69
Cellular Stress and General Pathological Processes
Gusev, E. Y., & Zotova, N. V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190319114641 · Cited by 69
Acapsular Cryptococcus neoformans activates the NLRP3 inflammasome
Guo, C., Chen, M., Fa, Z., Lu, A., Fang, W. Y., Sun, B., Chen, C., Liao, W., & Meng, G. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.08.013 · Cited by 67
“Early study shows that inhibitors of reactive oxygen species (ROS) block NLRP3-mediated caspase-1 activation by inhibiting the priming step in myeloid cells [32].”
BackgroundYang, Y., Zhou, X., Kouadir, M., Shi, F., Ding, T., Liu, C., Liu, J., Wang, M., Yang, L., Yin, X., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit347 · Cited by 61
“activation of the NALP3 inflammasome but not the AIM2 inflammasome [42].”
BackgroundRuwona, T. B., Xu, H., Li, X., Taylor, A. N., Shi, Y.-C., & Cui, Z. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.081 · Cited by 67
“In addition, NLRP3 activation in THP-1 cells by AH-NPs and AH-MPs, in the presence or absence of NAC, an antioxidant and glutathione precursor [20, 29], was evaluated by measuring IL-1β production.”
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome Inhibitors
Hill, J. R., Coll, R. C., Sue, N., Reid, J. C., Dou, J., Holley, C. L., Pelingon, R., Dickinson, J. B., Biden, T. J., Schroder, K., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700270 · Cited by 62
How the redox state regulates immunity
Mullen, L., Mengozzi, M., Hanschmann, E.-M., Alberts, B. M., & Ghezzi, P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.022 · Cited by 67
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
Choudhury, S. M., Ma, X., Abdullah, S. W., & Zheng, H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s295706 · Cited by 66
Dey, N., Sinha, M., Gupta, S., Gonzalez, M. N., Fang, R., Endsley, J. J., Luxon, B. A., & Garg, N. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111539 · Cited by 65
“The use of ROS scavengers controlled IL-1b activation by virtually all agonists of the NLRP3 inflammasome [33,34].”
BackgroundThe Interplay between NLRs and Autophagy in Immunity and Inflammation
Carneiro, L. A. M., & Travassos, L. H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00361 · Cited by 64
Sun, Y., Sun, H., Zhang, Z., Tan, F., Qu, Y., Lei, X., Xu, Q., Wang, J., Shu, L., Xiao, H., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117333 · Cited by 63
Jhang, J., Lu, C., Ho, C.-Y., Cheng, Y., & Yen, G. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b02605 · Cited by 63
Li, W., He, W., Xia, P., Sun, W., Shi, M., Zhou, Y., Zhu, W., Zhang, L., Liu, B.-H., Zhu, J., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00567 · Cited by 63
“To date, overproduction of ROS is considered to be the most prominent trigger (Bauernfeind et al., 2011).”
BackgroundGabelloni, M. L., Sabbione, F., Jancic, C., Bass, J. F., Keitelman, I., Iula, L., Oleastro, M., Geffner, J. R., & Trevani, A. S. (2013) · European Journal of Immunology · doi:10.1002/eji.201243089 · Cited by 55
Sulforaphane attenuates activation of NLRP3 and NLRC4 inflammasomes but not AIM2 inflammasome
Lee, J., Ahn, H., Hong, E., An, B., Jeung, E., & Lee, G. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.07.007 · Cited by 62
Mankan, A. K., Kubarenko, A., & Hornung, V (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04534.x · Cited by 55
Self-citationWang, Y., Wang, H., Qian, C., Tang, J., Zhou, W., Liu, X., You, Q., & Hu, R. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.015 · Cited by 61
Zhang, X., Zeng, W., Zhang, Y., Yu, Q., Zeng, M., Gan, J., Zhang, W., Jiang, X., & Li, H. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5130 · Cited by 60
“It was revealed that mtROS regulates NLRP3 initiation earlier than activation by upregulating its transcription (89).”
BackgroundExploring the anti‐inflammatory activity of sulforaphane
Treasure, K., Harris, J., & Williamson, G. (2023) · Immunology and Cell Biology · doi:10.1111/imcb.12686 · Cited by 60
“Finally, treatment of cells with ROS inhibitors blocks priming of the NLRP3, but not AIM2, inflammasome, reducing Nlrp3 expression, caspase-1 activation and release of IL-1b and IL-18.(109) Whether sulforaphane inhibits NLRP3 activation through the inhibition of ROS and subsequent NRF2 activation remains to be fully d…”
BackgroundKim, S.-J., Cha, J.-Y., Kang, H. S., Lee, J. H., Lee, J. Y., Park, J., Bae, J., Song, D., & Im, S. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.5.241 · Cited by 59
Pyroptosis and Redox Balance in Kidney Diseases
Cuevas, S., & Pelegrín, P. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8243 · Cited by 59
Loss of TLR2 Worsens Spontaneous Colitis in MDR1A Deficiency through Commensally Induced Pyroptosis
Ey, B., Eyking, A., Klepak, M., Salzman, N. H., Göthert, J. R., Rünzi, M., Schmid, K. W., Gerken, G., Podolsky, D. K., & Cario, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201592 · Cited by 56
“Abbreviations used in this article: CQ, chloroquine; dKO, double KO; DPI, diphenylene iodonium chloride; IBD, inflammatory bowel disease; IEC, intestinal epithelial cell; IL-1Ra, IL-1R antagonist; KO, knockout; MDR1/ABCB1, multidrug resistance gene; ROS, reactive oxygen species; RT, room temperature; tKO, triple KO; U…”
BackgroundA new mechanism of inhibition of IL-1β secretion by celastrol through the NLRP3 inflammasome pathway
Xin, W., Wang, Q., Zhang, D., & Wang, C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.036 · Cited by 58
The mitochondria in lung fibrosis: friend or foe?
Malsin, E. S., & Kamp, D. W. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.005 · Cited by 58
“Although the precise mechanisms by which mtDNA activates NALP3 inflammasomes in the setting of pulmonary fibrosis are not fully understood, mitochondrial ROS have been prominently implicated.(139,143,159) More recently, vimentin, the most abundant intermediate filament protein, was identified as another crucial molecu…”
BackgroundSilica particles cause NADPH oxidase–independent ROS generation and transient phagolysosomal leakage
Joshi, G. N., Goetjen, A., & Knecht, D. A. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-03-0126 · Cited by 59
“The interpretation of this measurement is difficult because cells were preactivated by either phorbol myristate acetate or lipopolysaccharide before exposure to silica, which results in generalized and nonphagosomal NOX activation and an increase in cellular ROS even before exposure to silica (Kahlenberg et al., 2005;…”
BackgroundVyleta, M. L., Wong, J. W., & Magun, B. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036044 · Cited by 57
“The production of reactive oxygen species (ROS) as a result of mitochondrial dysfunction has also been proposed as an activator of the NLRP3 inflammasome [8,11,12,13], although the validity of this conclusion has been questioned [14,15,16].”
BackgroundLemon, J. K., Miller, M. R., & Weiser, J. N. (2015) · Infection and Immunity · doi:10.1128/iai.00224-15 · Cited by 57
Bryant, C. E., Orr, S. J., Ferguson, B. J., Symmons, M. F., Boyle, J. P., & Monie, T. P. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009928 · Cited by 57
“In fact, the role of ROS in inflammasome activation may need revisiting in more general terms because of the observation that ROS inhibitors serve to block the priming and not the activation step of the NLRP3 inflammasome (Bauernfeind et al., 2011).”
BackgroundMancini, Ö. K., Lora, M., Cuillerier, A., Shum‐Tim, D., Hamdy, R. C., Burelle, Y., Servant, M. J., Stochaj, U., & Colmegna, I. (2017) · Circulation Research · doi:10.1161/circresaha.117.311400 · Cited by 57
Age-associated inflammation and implications for skeletal muscle responses to exercise
Kunz, H. E., & Lanza, I. R. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112177 · Cited by 56
“dysfunctional mitochondria (Bauernfeind et al., 2011; Carta et al., 2009; Tassi et al., 2009; Tsai et al., 2011) and mitochondrial dysfunction is a”
BackgroundMitochondrial fidelity and metabolic agility control immune cell fate and function
Sack, M. N. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120845 · Cited by 56
Dumont, A., de Rosny, C., Kieu, T., Perrey, S., Berger, H., Fluckiger, A., Muller, T., de Barros, J.-P. P., Pichon, L., Hichami, A., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1723-x · Cited by 56
Lipinski, S., Pfeuffer, S., Arnold, P., Treitz, C., Aden, K., Ebsen, H., Falk‐Paulsen, M., Gisch, N., Fazio, A., Kuiper, J. W., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018101266 · Cited by 56
“…(Jin et al , 1997; Weichart et al , 2006; Yu et al , 2010) and reactive oxygen species (ROS) also contribute to NF-j B-dependent NLRP3 priming (Bauernfeind et al , 2011), we hypothesized that Prdx4 deficiency might affect inflammasome priming leading to the observed differences in IL-1 b…”
Self-citationJiang, M., Li, R., Lyu, J., Li, X., Wang, W., Wang, Z., Sheng, H., Zhang, W., Karhausen, J., & Yang, W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01933-y · Cited by 51
Huang, T., Lai, H., Chen, Y.-B., Chen, L.-G., Wu, Y., Ko, Y., Lu, C., Chang, C., Wu, C.-Y., Martel, J., et al. (2013) · Innate Immunity · doi:10.1177/1753425913507096 · Cited by 55
A TSLP-complement axis mediates neutrophil killing of methicillin-resistant Staphylococcus aureus
West, E. E., Spolski, R., Kazemian, M., Yu, Z. X., Kemper, C., & Leonard, W. J. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaf8471 · Cited by 53
The NLPR3 inflammasome and obesity‐related kidney disease
Ke, B., Shen, W., Fang, X., & Wu, Q. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13333 · Cited by 55
“Moreover, ROS scavengers, such as N-acetyl-lysine (NAC), block the transcription of NLRP3 and pro-IL-1b but do not affect the direct activation of NLRP3 by classical NLRP3 agonists [61].”
BackgroundHo, C., Lin, C.-Y., Ka, S., Chen, A., Tasi, Y., Liu, M.-L., Chiu, Y.-C., & Hua, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075738 · Cited by 55
“adenosine triphosphate (ATP), which controls caspase-1 activation [18,19].”
BackgroundIcariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway
Zhang, L., Wang, X., Li, Y., Zhang, L., & Hao, L. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12161 · Cited by 54
ER-Mitochondria Communication in Cells of the Innate Immune System
Namgaladze, D., Khodzhaeva, V., & Brüne, B. (2019) · Cells · doi:10.3390/cells8091088 · Cited by 54
“ROS were also implicated in the inflammasome priming step [88] and IL-1β transcriptional activation [89].”
BackgroundCaffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome
Dai, G., Jiang, Z., Sun, B., Liu, C., Meng, Q., Ding, K., Jing, W., & Ju, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00721 · Cited by 54
“previously demonstrated that mitochondrial ROS regulates NLRP3 by blocking the priming step of NLRP3 inflammasome activation (28).”
BackgroundATP exposure stimulates glutathione efflux as a necessary switch for NLRP3 inflammasome activation
Zhang, T., Tsutsuki, H., Islam, W., Ono, K., Takeda, K., Akaike, T., & Sawa, T. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101930 · Cited by 54
Liu, A.-B., Tan, B., Yang, P., Tian, N., Li, J., Wang, S.-C., Yang, L., Ma, L., & Zhang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1487576 · Cited by 55
Wen, Y., Pan, M., Lv, L., Tang, T., Zhou, L., Wang, B., Liu, H., Wang, F., Ma, K., Tang, R., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27714 · Cited by 53
Metadata
- Authors
- Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Núñez, G., & Hornung, V.
- Affiliations
- University of Bonn (DE)
- University of Michigan (US)
- Corresponding author
- Bauernfeind, Franz
- Bartok, Eva
- Rieger, Anna
- Hornung, Veit
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07
- Volume
- 187
- Issue
- 2
- Pages
- 613-617
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3131480
- OpenAlex
- W1756750202
- Cited by
- 617
- References
- 25
- Citations by year
- 2026: 21 · 2025: 33 · 2024: 41 · 2023: 32 · 2022: 43 · 2021: 32 · 2020: 48 · 2019: 36 · 2018: 41 · 2017: 26 · 2016: 41 · 2015: 50 · 2014: 46 · 2013: 70 · 2012: 45
- FWCI
- 22.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Takeda Oncology
- National Institute of Allergy and Infectious Diseases (R01AI063331)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK091191)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- NLRP3 inflammasome, reactive oxygen species, inflammasome priming, inflammasome activation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, NADPH Oxidase 2, Animals, Biphenyl Compounds, Carrier Proteins, Cells, Cultured, Lymphocyte Activation, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Mutant Strains, Onium Compounds, Signal Transduction, Down-Regulation, Reactive Oxygen Species, NADPH Oxidases, STAT1 Transcription Factor, Mice, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.